To better study in vitro models of the brain, a localized delivery system is necessary due to the region specific functionality of the brain. The proposed system allows drugs and oxygen of controllable concentrations to be delivered. The delivery system is integrated into a polydimethylsiloxane microfluidic brain slice device and uses valves controlled by the LabVIEW programming language. Delivery is controlled by adjusting the opening/closing frequencies of the valves. Fluorescein isothiocyanate, a fluorescent dye, was used to characterize the delivery with and without brain tissue (∼300%µm). A linear relationship was found correlating the valve frequencies and the intensity showing how easily controlled concentrations can be delivered. A delivery system to automatically mix and deliver oxygen concentrations between 0% and 21% was developed. Accurate and precise outputs were obtained. Combined, these two delivery systems will allow controllable drug and oxygen concentrations to be tested at defined regions of the brain.
Introduction
Aristotle believed that the heart controlled perception and thought. After two millennia of research, it is now widely accepted that the brain is the real heart of the matter. The complexity of the brain and its astounding ability to process and relay all the signals and information of the body has made it exceedingly difficult to understand the functional relationship of areas in the brain. The complex relationship presents a barrier to better understanding and treating neurological and trauma related disorders.
To better understand the functional relationship of individual areas of the brain, electrophysiologists use a combination of recording/stimulating electrodes and chemicals. In vivo experiments are often challenging as the stimulation of one region can be dictated by a number of interconnected pathways that may also activate other regions of the brain. Additionally, the in vivo environment makes it seemingly difficult to locally deliver and remove chemicals in a controlled manner. Alternatively, brain slice preparations have proven invaluable as a physiological tool for investigating intrinsic cellular mechanisms of brain circuitry. 1 In combination with brain slice perfusion chambers, in vitro brain slice models allow researchers to determine the exact nature of each region by isolating a specific neural networks, thereby reducing the input pathway activity from other connected areas.
It is necessary to test the response of specific locations of the brain due to the brain's spatial organization of its processing centers.
2 Therefore, most brain slice perfusion chambers use an open top bath design to provide nutrients to the brain slice and access for electrophysiology tools.
3 A micro-injector pipette is typically utilized to inject a solution in a site on the brain slice. However, the design of typical perfusion systems makes testing drugs and chemicals on highly localized areas of the brain very difficult. The open bath design causes the chemical to diffuse outward away from its intended target unless the pipette is very close to the tissue, but even then it is not guaranteed that the chemical will diffuse all the way through the tissue. Additional precaution must also be taken to prevent the tissue from being disturbed as the flow rate of the perfusate and/or puffing of chemicals from the pipette may cause the tissue to move out of place or compress the tissue at the target site. Moving the tissue out of place will cause any electrophysiological sensors that are set to record at the specific location to take measurements in the incorrect location. Compression of the tissue will cause unwanted mechanical stimulation to contaminate the electrophysiological effects of the drug itself. 4 Furthermore, pipette systems also cause the microfluidic brain slice device (µBSD) to become crowded making placement of the electrophysiological sensors to be difficult as well as interfering with any microscope being used. 5 Whenever the drug needs to be applied to a new area, either the pipette system needs to be moved, or another one must be placed in that new area. If multiple areas are to be tested, then the open bath area can quickly become crowded.
Here we present a type of perfusion chamber, the µBSD, for maintaining the viability of brain slices and controlling the spatiotemporal delivery of solutions to specific areas of the brain slice. The µBSD was constructed using poly(dimethylsiloxane) (PDMS) microfluidic technology, as it is an inexpensive and flexible platform for rapidly prototyping modifications until an optimal design is achieved. 6 The µBSD allows a brain tissue slice to be placed inside a microfluidic chamber through which oxygen and nutrients can be delivered to maintain the brain slice's viability. 4 The microscale dimensions of the fluid chamber significantly reduce the perfusate volume, thereby promoting a faster exchange of oxygen and nutrients at the tissue-fluid interface. Consequently, lower flow rates can sustain the viability of thick tissue slices. 7 Perfusion chambers are important in order to model and study processes such as ischemia and epilepsy, as well as study protein expression.
3 A partic-ular application we would like to observe is inducing a physical trauma like stroke. Forcing a specific area of the brain to undergo hypoxic, or low oxygen, conditions can create a stroke model that can be observed using a number of electrophysiology tools. The µBSD can be integral in the prevention or treatment of stroke by measuring the effectiveness of different drugs being applied to hypoxic areas.
The proposed µBSD design in this experiment utilizes VIAs (through-put channels) that can deliver the chemical or drug from underneath the brain slice. The flexibility in the design and manufacturing of the µBSD can also allow specific locations of the brain to be targeted and control the spatiotemporal delivery of solutions. By having the VIA delivery ports placed at the bottom, the open bath remains uncluttered to allow more access for electrophysiological tools and microscopes to the slice. Mechanical solenoid valves, which are compatible with most chemicals, are utilized to deliver the solutions in a controlled manner and prevent the tissue from being disturbed. To automatically regulate delivery, a digital signal sequence is programs the valves through a Lab-VIEW program. By varying the VIA diameter and the frequency at which the valves open and close, we can manipulate the concentration profile of the solution being delivered.
In addition to laying the groundwork for the automated delivery of solutions, we have automated a delivery system for premixing 0% and 21% oxygen concentrations to a desired concentration. The main conception of the automated delivery system is automation and programmability of the code such that after defining parameters such as the oxygen level and the duration of exposure, an experiment can be run without needing further attendance for the oxygen. Both delivery systems share the same type of valve as well as the LabVIEW based interface. A graphical user interface (GUI) was developed for each delivery system to allow the user to program the quantity that is delivered. For both delivery systems, it was hypothesized that there would be a linear relationship between the manner in which the valves were oscillated to release their contents and the concentration of the output. A linear relationship would allow a simple and controllable method for delivering various concentrations. Other features were implemented for each delivery system as well in order to facilitate the automation of each system and will be detailed later in the paper. To sum, the final chemical and oxygen delivery system should feature high spatial resolution, interfacing with other sensors, non-interference with the tissue, and automation.
FIG. 1:
The valve and tubing set up for the oxygen delivery system is depicted. The valves would mix different oxygen concentrations together by opening and closing at different frequencies to form a final oxygen concentration output. The two valves came from the Lee Micro Dispensing VHS starter kits. One valve was connected to a 0% oxygen gas tank, and the other was connected to a 21% oxygen tank. A y-connector combined their outputs into the Cole-Parmer EW 06498-62 tube which was 40.1cm long to allow sufficient time for the different oxygen concentration gases to mix. Not shown in the diagram was the NeoFox FOXY sensor that would detect the output concentration.
Materials and Methods

Automated Oxygen Delivery System
Equipment Set-Up
The oxygen delivery system (Figure 1 consists of two Lee VHS micro-dispensing starter kits containing voltage-controlled micro-nozzle valves.
8 A 0% oxygen tank feeds into one valve while a 21% oxygen tank feeds into the other. Regulators are placed on these lines to adjust and ensure equal flow rates to each valve. A y-connector combines the outflow of each valve, and the total combined output travels through a 15.8 inch long Tygon tube with an inner diameter of 1/16 inch (Cole-Parmer EW 06408-62, Vernon Hills, Illinois) before reaching a FOXY (fiber optic oxygen) probe which senses the percent oxygen level. The VHS starter kits come with a microcontroller box which can be fed signals from a National Instruments DAQ card. Through the DAQ card, LabVIEW is able to output digital signals to open and close the valves.
Calibrating the Oxygen Levels
Before any oxygen levels could be set, the FOXY (Ocean Optics, Inc.) software had to be calibrated to the standards. This calibration had to be performed period- ically, every 30 minutes, to ensure accurate results. An Ocean Optics NeoFox Oxygen sensor system was used to measure the oxygen concentration. This sensor detects the fluorescence level at the tip of a probe which is quenched by oxygen concentration. A spectrometer measures the degree of quenching which can be used to determine the output of oxygen. The standards used were the 0% (5% carbon dioxide and balanced nitrogen) and 21% oxygen gases which are typically carried by gas distribution companies. Afterwards, equal flow rates were set through each valve by adjusting the regulators. For validation that equal flow rates were achieved, the regulators were slowly manipulated to read the same output. Then further tunings were applied until 10.5% was detected by the FOXY sensor. If both gases were flowing at the same rate, then the combined outflow should consist of equal amounts of the 0% and 21% gas resulting in an average output of 10.5%. Through LabVIEW, the valves were coded to sequentially open and close such that only one valve was open at any given time ( Figure  2 ). This method generated more stable results rather than keeping one valve open constantly while adjusting the opening/closing frequency of the other. It introduced too much oscillation in the output mixture. The sequential valve control system allowed packets of 0% and 21% to diffuse and mix with each other resulting in a more uniform and consistent output.
LabVIEW GUI for Oxygen Delivery System
The main purpose of the GUI (see Figure 3 ) was to be able to output an integer oxygen concentration between 0% and 21%. The user is able to use a slider to input the desired concentration or simply type the number in. When the program is activated with a Start/Stop button, LabVIEW would use the calibrations that were discov-FIG. 3: The LabVIEW GUI was developed for use with the automated oxygen delivery system. The components will be briefly explained clockwise starting from the upper left corner. The total elapsed time displays the length of time that has passed since the program was initiated using the Start/Stop button. The target time reached light activates once the total elapsed time matches the total delivery time. The testing section allows the user to manually and independently open and close the valves to make sure the correct oxygen tank is connected to the valves. The intervals section allows you to choose the different oxygen intervals that will be cycled through sequentially and repeatedly. Each oxygen interval is defined by an oxygen concentration and a duration. The Start/Stop button starts the program and can stop it at any point. The total delivery time can be set such that the program will stop once the time has bee reached. The oxygen cycling section contains a more detailed version of the oxygen intervals.
ered to output that oxygen concentration. The GUI also allows the user to define a set time for which the oxygen concentration would be outputted. A total elapsed time begins and is displayed once the Start/Stop button is pressed. Pressing the button again will stop the time and close all valves. If the defined delivery time is reached, the valves are closed, the timer is stopped, and the user is notified via a bright green light on the GUI. For calibration purposes, each valve can be manually and independently opened and closed using toggles to ensure that the correct gas lines are connected to the valves. The final feature of the GUI is the ability of the user to program different intervals of delivery. Each interval consists of a user defined oxygen concentration as well as a duration for which the concentration will be outputted. The user can specify up to 5 intervals. If the sum of the durations of all of the activated intervals do not exceed the user specified total delivery time, then the intervals will repeat again from the beginning interval. In this manner, experiments can be performed where the brain is subject
This is a bird's eye view of the basic µBSD that was tested. The bottom layer is the microchannel layer which contains the microchannel. The reservoir layer sits on top and contains an outlet reservoir and the main bath chamber. The outlet port delivers any unused chemical to an area outside the main bath chamber where it can be removed via a vacuum line. The output reservoir prevents the vacuum's suction from disturbing the bath chamber. The bath chamber is where the tissue would be placed. A channel opening is placed in the bath chamber so that the chemical can be delivered to the tissue. A T channel sits on top of the reservoir layer. The T channel's top opening is connected to a DI water line which acts as a transport medium for the delivered chemical. The side branch is connected to the valve through which the chemical is delivered.
to different oxygen environments automatically.
Microfluidic Brain Slice Device (µBSD) with Chemical Delivery System
Description of the µBSD
The device consisted of 2 polydimethylsiloxane layers as well as one T channel manifold ( Figure 4 ). The bottom layer, or the microchannel layer, contained the microchannels (150µm in width), each having an inlet port but a combined outlet port on the other end ( Figure  5 ). The top layer, or the reservoir layer, was a block of PDMS with a reservoir which would hold the tissue and the bath reservoir. A channel would run through this layer starting at the inlet ports of the microchannels at the bottom of the reservoir layer to the top of the layer. The T channel manifold was placed on the channel that emerged from the reservoir layer. placed to remove influx of DI water. However, the chemical to be delivered does not reach the tissue through the outlet port. Between the inlet port and outlet port, is a channel opening through which the chemical will travel to interact with the bathing fluid and tissue. The width of the opening matched the width of the channel (150 µm ), but the height of the opening was variable as is detailed later. Finally, a line from a syringe pump was placed to flow a constant stream of water over the slice to wash away any chemical that would diffuse through the tissue. The excess chemical would be directed toward the outlet port for the vacuum pump to remove.
Creating the µBSD: Soft Lithography
The primary material of the µBSD was polydimethylsiloxane (PDMS). PDMS was chosen because of its biocompatibility, flexibility, optical translucency, inexpensive cost, and easy use.
410? In order to create the microchannel layer µBSD, a master needed to be made upon which PDMS could be poured to form one layer of the µBSD. Photolithography was used to construct the µBSD master. A 250µm layer of SU8, a negative photoresist, was spun onto a silicon wafer. The layer was then baked on a metal hotplate to establish cross-linking of the SU8 into a more solid structure. A mask containing the µBSD design of the particular layer was laid over the SU8, and the wafer was exposed to ultraviolet (UV) light to degrade any SU8 that was not protected by the mask. After another bake to further strengthen and cross-link the SU8 that wasn't UV-exposed, the wafer was subjected to a developer's solution to eliminate the UV-exposed SU8. In this manner, the master was constructed. From the master, the actual µBSD was constructed by pouring a PDMS mixture onto the master. The PDMS mixture was created by combining the PDMS curing agent and silicone elastomer in a 1:10 ratio. The master with the PDMS was spun to form a 250µm layer, and the entire construct was baked until the PDMS hardened and peeled easily away from the master. This procedure was performed to create the bottom layer of the µBSD.
To form the reservoir layer, PDMS was poured into a petri dish and baked. The resulting shape was then cut using a razor blade to the appropriate dimensions before a hole was punched using a cylinder to form the reservoir. The T channel manifolds were constructed similarly except that small cubes of PDMS were cut from the main batch. A syringe was used to punch a main channel out the cube. Then a side branch was created using the syringe. Special care was given to remove any PDMS from the channels after the holes were punched so the flow through the channels would not be obstructed.
LabVIEW GUI for Chemical Delivery System
The LabVIEW GUI for Chemical Delivery System is shown in Figure 7 . Starting and stopping the program
The chemical delivery GUI is depicted. It is currently set up to control up to three valves. An elapsed time since delivery began is displayed, and a total duration can be set to stop delivery upon reaching the set time. When the Go/Stop button is pressed, only the valves activated by their corresponding toggles run through their programming. The milliseconds open and closed control the pulses, and the repeat window allows the pulse series to be delivered. A full dose delivery has a repeat of 1 while the pulsing dose method has multiple repeats. The Every X Seconds option allows the delivery to repeat every X seconds. The color coding of the aforementioned windows matches that below the other valves, and the colors dictate the function of the number control of that window. A camera system allows visualization of the slice area with control of the brightness, gain, and shutter speed. The calibrate valves toggle allows the user to click on the location of the valve openings which is saved as an overlay. The overlay switch can turn the overlay on or off.
is controlled with a Go/Stop button. There are three toggles for each of the valves that would lead to a different microchannel. The programming that dictates their delivery style only runs when they are armed by setting their toggle to "on." Delivery will then proceed when the Go/Stop button is activated. Again, a total delivery time can be set which will stop the program once the user defined time has been reached. Delivery can be prematurely terminated by clicking the Go/Stop button again which closes all valves. The valve delivery can be manipulated by changing the pulses (Figure 8) . A pulse is defined by a specified amount of time the valve is open in seconds and a specified amount of time the valve is closed. The pulses can be sequentially repeated in a delivery known as a series of pulses or, simply, series. These series are repeated until the total delivery time is reached or the program is stopped. The interval at which the series are repeated can also be set by the user. One problem with the delivery system is that after placing the tissue into the µBSD, the locations of the channel openings will be covered. The actual target area of the channel opening will be unknown, so the user will FIG. 8 : The different delivery methods tested in the experiment are displayed. The full dose method has one opening time and one closing time. The pulsing dose method opened the valve for an equivalent amount of time as the full dose method. However, they were spread out in smaller pulses. A pulse was defined as one opening and closing time. Essentially, a full dose method was just one long pulse. The closing time of the pulse is also known as the wait time, and a train of sequential pulses was known as a pulse series.
not be able to know exactly where the drug is being delivered. Thus, the GUI can display the image that a camera can obtain through the microscope. A channel opening location calibration toggle is in place such that when activated, the locations of the channel openings can be clicked upon before the tissue is placed. These locations are saved and can be overlaid over the camera image even after the tissue has been placed. In this way, the locations of the channel openings can still be known assuming that the camera's field of view has not changed or the µBSD has not been moved. This overlay can be toggled on and off as well. The camera's gain, shutter speed, and brightness can be controlled via the GUI, and the frame rate of the camera is displayed as well.
Characterizing the Chemical Delivery System
Fluorescein isothiocyanate (FITC) was used to characterize the delivery system because the delivered concentration could be related to the intensity that is recorded by the camera (Figure 9 ). The microscope camera used to record the images was manufacture by Hamamatsu, and the recording software was Wasabi. This characterization was performed with and without tissue. The reservoir was allowed to be filled with DI water. Flow of the DI water and FITC was driven by gravity. Regula-FIG. 9: The experimental set up for testing the chemical delivery system is shown. The µBSD is set on the stage of a microscope which is integrated with a camera that can measure flurorescence. FITC is injected by the valve into the T channel. DI water lines flow into the T channel and over the surface of the bath chamber. A vacuum line rests near the outlet chamber to remove waste and prevent overflooding of the chamber. A brain harp is depicted which is placed over the tissue slice in the bath chamber to prevent it from moving once the microscope has been set.
tors were placed on the lines to ensure a constant flow rate of 60 mL/hr for the FITC and 20 mL/hr for the water. The Lee valves were used for this delivery as well. When tissue was used, approximately 300m brain slices were obtained from adult black 6 mice. Slices were obtained using the Vibrotome Series 1000. Because the tissue was needed only to study the diffusion characteristics of FITC through the slice, artificial cerebral spinal fluid was not used to mainta in the tissue's viability. The slice was placed over the channel openings in the reservoir and was held in place using a brain harp which was stringed with strands of nylon. Nylon was chosen because of the thinness of each strand as well as its inertness with respect to the brain tissue.
1 The brain harp was required to keep the tissue in place while the flow of DI water passed over it from the syringe pump.
Delivery Methods: Full Dose and Pulsing Dose
Two different delivery styles were compared: the full dose method and the pulsing dose method. For this report, "pulses" described the pulses of FITC being delivered by the valves. The output was referred to as the bolus. The full dose method involved opening the valve for a set amount of time before closing the valve. This would constitute one full dose. A pulsing dose opened the valve for a small increment of time before closing it, but instead of increasing the time at which the valve was left open, the number of times the pulses were repeated in succession was repeated. A full dose was defined by the length of time the valve was open, and the pulsing dose was defined by the number of pulses that were repeated. However, in choosing the trials, the open valve times and the number of pulse repeats were chosen such that the total amount of time the valve was left open was the same for both methods. For example, if a full dose of 10ms was chosen, then a pulsing dose of 2 repeats of 5ms were performed. The two 5ms pulses sums to a total open valve time of 10ms. Without tissue, each bolus was injected every 6 seconds. However, this interval was changed to 10 seconds when the tissue was in place because saturation occurred.
Exposure Time: 15.005ms
Gain: 125
Offset: 55 Channel Opening Height: 50µm
All of the characterization data was processed in the form of intensity profiles. Intensity profiles were generated by defining a region in the movies (in .avi format) taken by the camera. ImageJ, an image analysis software, then could measure the intensity values within the region. When analyzing the comparison between the full dose and pulsing dose method without tissue, a rectangular region was defined through which the analysis of each bolus of a certain setting was performed. Thus, an area of effect could be seen as well as the spatial distribution of the intensity of the bolus.
The analysis for the full dose and pulsing dose comparison with tissue used a line to generate the results. A time lapse profile was created showing the average intensity in the affected area of tissue over time. This was performed to discover the average concentration of FITC that would be delivered to the tissue over a period of time at the given settings. Thus, the decay of delivery could be studied as the concentration decreased with time.
Optimizing the Pulsing Dose
The effect of different closing times between each pulse was tested. This test was performed by injecting a series of 6 pulses with different wait times between each pulse. One bolus would be formed by this series. It was hypothesized that different pulse closing times would change the shape of the bolus delivered. Pulse intervals of 50ms, 100ms, 125ms, and 175ms were tested. Multiple boluses were recorded and averaged together to generate an average bolus profile. The ImageJ intensity profile was based on the intensity that passed through a line crossing the channel width. This way, the duration of the bolus could be monitored over time.
Exposure Time: 7.528ms
Gain: 255
Offset: 0 FIG. 10: A scatter plot of the output of the oxygen delivery system was made. The desired output at each step was an integer value between 0% and 21%. Each step was run for 150 seconds, but there exists oscillation in the output. However, the average output from each step is very close to the desired output. The oscillations stem from the error in the NeoFox FOXY sensor used to detect the oxygen concentration as well as the sequential nature of the oxygen mixing technique (Fig. 2) .
Channel Opening Height: 50µm
Results and Discussion Automated Oxygen Delivery Figure 10 depicts the output of the dual valve system after the calibrations had been made. A sequential step up can be seen from 1% to 21% in which the average value of each plateau resides around an integer between 0 and 21 percent. Each oxygen level was programmed to run for 150 seconds. For certain oxygen levels, predominantly those between 11 and 21 percent, rapid and high amplitude oscillations of the detected oxygen level cause thick lines to appear. The absolute difference between the average output and the desired oxygen percent was calculated rather than performing relative error analysis. Because of the weighting of the numbers, deviations in the lower oxygen levels would translate into more relative error than higher oxygen levels. Therefore, only a difference was calculated.
The data collected for Table I suggest that the calibrations for the oxygen levels are fairly accurate because the average values are very close to the desired oxygen levels. The absolute difference ranges from 0.009847% to 0.255671%. The standard deviation is also very low (0.038476% to 0.171212%) suggesting that the calibration outputs are very precise. However, the calibrations can be further refined to output more accurate and more precise results, and this will be performed in the future. Complete accuracy and precision cannot be guaranteed, though. The design of the FOXY sensor introduces vari-
Difference (%) Deviation (%) Figure  9 was assembled in this table. The standard deviation was also calculated to obtain the precision of each result. An absolute difference was taken as a measure of accuracy rather than calculating relative error because the weighting of the desired values would underestimate the relative error for higher concentrations.
ability in the data collected. For example, the 21% data, which comes from a standard gas tank set to 21%, does not have the lowest standard deviation nor does it have the lowest absolute difference from the desired oxygen level. However, part of this error may be caused by the drift in the FOXY sensor calibration as the experiment proceeds. Further error may be caused by the manufacturing of the standard gas tanks because it cannot be guaranteed that the oxygen level contained within is exactly 0% or 21%.
Chemical Delivery System
Pulse Separation Times
The 50ms wait time formed a shape with a steep, positive slope at the forefront (Figure 11 ). The initial increase in intensity follows a fairly smooth shape. This was followed by a rapid, relative to the other wait times, decline towards the base level. The resulting bolus is thin meaning high concentrations are delivered in a very short amount of time. Because the wait time between FIG. 11: The wait times for a pulse series were varied.
FITC was tested, and the temporal profile was generated using the relative intensity. Measurements were taken from within the microchannel. The wait times are identified by the "closed" label and are defined to be the time that valve is closed in between each pulse in a series of pulses. 50ms, 100ms, 125ms, and 175ms wait times were tested for a pulse series consisting of 6 pulses.
each pulse is only 50ms, the pulses stack and compress each other to form this shape. Finally, this wait time resulted in the largest maximum. Waiting 100ms between each pulse results in a wider bolus meaning the concentration is delivered more slowly. The shape of the bolus at the front is irregular meaning that the concentrations are not as uniformly delivered. Each pulse adds to the overall concentration until a peak is reached. Therefore, a step is seen before the peak which again shows that the delivery is not homogenous. The peak also does not stay constant for a long duration, approximately 35ms.
An almost symmetrical distribution is seen with the 125ms wait time. Comparing the build up to the peak intensity and the decay, the two are similar. However, instead of reaching a constant peak, three local maxima are reached, the middle one being a global maximum. Contrary to the 100ms wait time, a step is not seen before the peak region arrives. This may be due to the faster pulsing of the 100ms. For the 100ms wait time, the first four pulses may have compressed and grouped together forming that first step similar to the 50ms bolus. However, the final two were grouped and added to the first 4 pulses to form the maximum peak.
The 175ms wait time clearly distinguishes the different peaks due to the 6 pulses used to form the bolus. Each pulse sequentially builds off the intensity of the preceding pulse causing higher and higher peaks. Thus, a homogenous delivery is not achieved because there is no appre- was calculated resulting in a higher R 2 value for the pulsing dose method. ciable amount of time in which a constant intensity is delivered.
The ideal delivery is being described as homogenous meaning that a constant, consistent bolus is being delivered by the pulse style. As the wait times are increased between each delivered pulse, it is logical that the width of the bolus also increase because the delivered pulses are spread out in time. However, the most favored wait time was the 125ms wait times. All the other styles outputted never stabilized to a single concentration, but the 125ms wait time resulted in three peaks that returned to a relatively common local minimum. Also, the symmetrical distribution over time and the large width of the profile suggest a more controlled form of delivery. A slower release of concentration prevents sudden or violent releases from the channel opening that can damage the tissue. Therefore, the 125ms wait time was chosen for the pulse dose method for the future trials.
Full Dose vs. Pulsing Dose: Without Tissue
The results depict an average intensity profile compiled from multiple boluses that emerged from the channel opening without tissue (Figure 12 ). These profiles were obtained 1.2 seconds after the FITC began to emerge. The figures show that the full dose method outputs a smaller bolus with a maximum width of 860µm. A width of 1320µm results from the pulsing dose method. Therefore, the full dose method would allow a higher specificity in the location of application because it can affect a smaller radius of tissue. The difference in bolus radius is attributed to the pulsing method delivering a small amount of FITC multiple times. Because small quantities are released, the bolus would diffuse out more. The way that the pulses are released may cause the subsequent pulses to collide with and spread out previous pulses resulting in a greater area of effect. A tighter radius is seen with the full dose method because the valve is open for a singular amount of time which would cause the FITC to emerge more like a jet which would lessen radial diffusion. This jet also explains the higher maximum that the full dose method achieves.
Both methods show an increase in maximum and overall intensity as their variable factor increases. For the full dose method, higher intensities are outputted as the total valve time increases, and the intensities are also shown to increase as the number of repeats increases for the pulsing dose method. However, a closer study upon the linearity of these increases was performed because a more linear relationship would make it easier for the user to control the concentration delivered. A trend line was fitted through the maximum intensities in order to determine this linearity. The full dose method resulted in a linear equation with an R 2 value of 0.880 while the pulsing dose method resulted in an R 2 value of 0.99744. The full dose method also seems to better fit an exponential equation rather than a linear equation. However, it is clear that the pulsing dose method has a linear relationship between the number of times the pulses are repeated and the intensity that is produced based on the trend line's R 2 value and the distribution of its maximum intensity points.
Full Dose vs. Pulsing Dose: With Tissue
A time lapse was performed measuring the intensity at the affected tissue region over two minutes (Figure 13 ). The timing of the delivery was set such that each delivery would occur 10 seconds apart over the time period. The full dose delivery resulted in a less stable delivery in that the concentration oscillated with greater amplitude. Conversely, the pulsing dose method resulted in a more consistent concentration level. The delivery had less variability than the full dose delivery showing that the delivery method was more stable. The higher amplitude nature of the full dose method stems from its singular open time which results in a large concentration of FITC being delivered at once. The sudden introduction of FITC causes the higher spikes to occur. The equally sudden closing of the valve causes the concentration levels to drop which is why there is a slower, curved negative slope after the spike peaks. Pulsing the delivery spreads out the duration at which the FITC is applied. This leads to a more gradual increase in intensity as well as a FIG. 13: The temporal profile of boluses delivered by full dose and pulsing dose methods were calculated with tissue using FITC. Boluses for both delivery methods were delivered periodically resulting in different baseline oscillations depending on the valve open time for the full dose method or the number of pulses for the pulsing dose method. The average or baseline intensities were calculated and plotted against their independent variable. A linear fit was calculated resulting in a higher R 2 value for the pulsing dose method.
more gradual return to lower intensity levels. However, both methods output an intensity that oscillates about some dc offset level. The average output would correspond to this offset and is related to the valve open time and number of pulses. Again, the delivery methods were compared to test for a linear relationship between the delivered intensity and the delivery style. When plotting the average intensities against the different valve open times, a linear trend line with an R 2 value of 0.898 was calculated. However, the pulsing dose method resulted in a linear equation with an R 2 value of 0.972. As with the delivery without tissue, the pulsing dose method proved to have a more linear relationship with the outputted intensity.
Conclusion Automated Oxygen Delivery
Robustness
The automated oxygen delivery system resulted in precise and accurate outputs that were very close to the desired oxygen concentration as well as having low amplitude oscillations. When the standard 21% oxygen was used, the detected oxygen varied by approximately ±0.26%. Table 1 shows that the oxygen output from the delivery system only maximally oscillated by ±0.16%. This shows the precision of the delivery system. The variation seen by the 21% standard could be due to the changing pressurization of the tank as oxygen is released. The small pulses of the delivery system enable a more controlled release of gas from each tank resulting in greater precision. However, additional tweaks to the calibration can be made to increase the accuracy of the outputs even though the absolute difference between the average output and the desired output is already very minute. In biological systems, it is impossible to have constant oxygen environment conditions, so the acceptable range of fluctuations could include up to ±1%. Besides the use of regulators and the 10.5% check, another method needs to be developed in order to ensure the robustness of the calibrations. The better solution to ensure equal flow rates would be to have actual flow rate monitors in each gas line. If these flow rate monitors were to be in place such that each flow rate is known, the calibrations could be more easily standardized among different set ups.
Future Work
Application of this delivery system into the µBSD would be simple. The output line would bypass having to go through a T channel manifold but instead connect directly into the channel at the top of the reservoir layer. Thus, the desired oxygen concentration can be bubbled through to the specific location on the tissue slice being tested. The current system consists only of two valves and outputs a range from 0% to 21%. By adding another valve connected to 100% oxygen gas, the output range could be increased to 0% to 100%. If an output concentration between 0% and 21% were desired, the 0% and 21% tanks would be used. Above that, the 21% and 100% tanks would be used. However, the larger the difference between two gas concentrations, the more difficult it is to maintain a stable output meaning that the oxygen output at around 60.5% would suffer.
Chemical Delivery
Optimizing Pulse Width
It was found that a wait time of 125ms created the most optimal bolus for the pulsing dose method. The bolus generated had an almost symmetrical distribution through time and a longer, though fluctuating, peak region compared to the other wait times.
Large increments were given for each wait time tested. A better wait time could be found if 25ms and 50ms increments were not chosen. Averaging more boluses would also show a more representative bolus from the wait time. Because the pulse was defined as both the opening time as well as the closing time, additional tests could be made on changing the 5ms opening time that was consistent through all of the trials. Logically, a longer opening time should just yield higher intensities, but the wait time may also need to be adjusted for any changes to the opening time as well.
Chemical Delivery System: Full Dose vs Pulsing Dose
Without tissue, the full dose method was able to deliver boluses that were smaller in width (approximately 860µm) meaning that a higher spatial resolution could be achieved with this delivery style. Channel openings could be placed closer together without having the chemical affect unwanted regions. However, the relationship between its maximum intensity and open valve time were not so linear. The pulsing dose method achieved a very linear relationship between the maximum intensity at the cost of spatial resolution. It delivered a wider bolus (approximately 1320µm). With tissue, the pulsing dose method achieved a more constant concentration than the full dose method, and it also had a stronger linear relationship between the average concentration of the tissue and the number of pulses. Therefore, although there is less spatial resolution, the pulsing method is the preferred method of delivery due to the linearity and its more homogenous delivery over time. Due to the linearity, the delivered concentration is easier to control allowing the user greater flexibility when dealing with delivering varying concentrations from the same valve.
However, the delivered bolus width using the pulsing dose method of 1320µm is too large to target the small brain structures of the mouse. Decreasing the bolus width is ideal in order to increase the spatial resolution of the device. Therefore, additional variables need to be tested such as the size of the channel opening. Also, the shape of the bolus could also be altered by altering the shape of the channel opening. The intensity plots in Figure 12 show an almost Gaussian distribution along one axis for the full dose method and a less Gaussian but more linear distribution for the pulsing dose method. A spherical bolus was intended due to the spherical shape of the channel opening. Due to the laminar flow delivery and diffusion, a bolus that has constant intensity throughout cannot realistically be made, so the Gaussian distribution is acceptable. By decreasing the distance traveled from channel opening to tissue, the effects of diffusion can be reduced. Figure 12 also shows that the location of peak intensity is not exactly in the center. This can be attributed to the flow generated by the vacuum line. Further experiments could also help determine how to optimize the removal of accumulating drug in the bath as well as limiting its effect on the delivered bolus.
The relationship between the full dose's open valve time and maximum intensity for the no tissue experiment seems to be exponential rather than linear. This also may be true for the pulsing dose method. In order to better understand the relationship between the intensities and the respective variables, more tests should be performed with more repeats or different open valve times in order to truly understand the relationship. However, if the linear relationship for the pulsing dose method holds true, then this chemical delivery system can be tested using actual drugs on brain slices. For example, dopamine could be delivered and quantified using cyclic voltammetry. 4 The proposed method of delivery would be to load a known concentration of drug into the device which would be the maximum concentration. The various pulses would deliver a percentage of the maximum concentration depending on the number of repeats for the pulse series. The linear relationship would allow an easy calculation on what is actually delivered based on that maximum concentration.
